Journal: The Journal of Biological Chemistry
Article Title: Integrated analysis of the adipocyte plasma membrane proteome reveals KCC1 and PIT2 as novel insulin-responsive transporters
doi: 10.1016/j.jbc.2026.111282
Figure Lengend Snippet: Analysis of multiple adipocyte PM proteomic datasets. A , schematic of the insulin treatments and PM isolation methods in different PM proteomic datasets. DS, datasets. LC-MS/MS, liquid chromatography-tandem mass spectrometry. GO-CC, Gene Ontology cellular component. B , UpSet plot showing the overlap of insulin-regulated ( p < 0.05) integral PM proteins across PM proteomic datasets with ≥3 biological replicates. C , Heatmap of 37 integral PM proteins identified by meta-analysis as significantly insulin-regulated and detected in ≥3 datasets. Values represent log 2 insulin-over-basal fold change (FOB); ND, not detected. D , insulin responsiveness of IRAP, GLUT4, TFR, KCC1, and PIT2 across nine datasets. E , Spearman correlation between IRAP, GLUT4, TFR, KCC1, and PIT2 mRNA expression in subcutaneous adipose tissue and metabolic clinical features. Figure generated from adiposetissue.org using data from ( , , , , , , , , , , , , , , , , , , , , ) (∗ pFDR < 0.05, ∗∗ pFDR < 0.01, ∗∗∗pFDR < 0.001). BMI, body mass index; circ, circulating; CRP, C-reactive protein; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment for insulin resistance; iso, isoproterenol; LDL, low-density lipoprotein; LEP, leptin; TG, triglycerides; WAT, white adipose tissue; WHR, waist-to-hip ratio. PM, plasma membrane; IRAP, insulin-regulated aminopeptidase; TFR, transferrin receptor; PIT2, sodium-dependent phosphate transporter 2; GLUT4, glucose transporter 4; pFDR, positive false discovery rate.
Article Snippet: Immunoblotting was performed using primary antibodies pan-AKT (Cell Signaling Technology, Cat. #2920), phospho-AKT (Thr308) (Cell Signaling Technology, Cat. #13038), SLC20A2 (PIT2) (Proteintech, Cat. #12820-1-AP), SLC12A4 (KCC1) (Proteintech, Cat. #15927-1-AP), GLUT4 (rabbit polyclonal antibody generated in-house), Caveolin 1 (CAV1) (Abcam, Cat. #ab17052), 14-3-3 (Santa Cruz Biotechnology, Cat. #sc-629), and either infrared dye 700- or 800-conjugated secondary antibodies (Thermo Fisher Scientific, Cat. #A32735 or A21036).
Techniques: Isolation, Liquid Chromatography with Mass Spectroscopy, Liquid Chromatography, Mass Spectrometry, Expressing, Generated, Clinical Proteomics, Membrane